Versant Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Versant Capital Management's RARE Position: Q3 2026 in Review
Versant Capital Management increased its Ultragenyx Pharmaceutical (RARE) stake by 122% in Q3 2026, buying an estimated $33.7K and bringing the position to 2,556 shares worth $38.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1592.
Versant Capital Management first reported a position in RARE in Q2 2023 and has held it in 11 quarters since. The position peaked at $38.5K in Q2 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Versant Capital Management held 2,556 shares of Ultragenyx Pharmaceutical worth $38.4K as of Q3 2026.
- Versant Capital Management bought 1,404 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $33.7K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1592 holding.
- Versant Capital Management first reported a position in Ultragenyx Pharmaceutical in Q2 2023 and has held it in 11 quarters since.
- Versant Capital Management's Ultragenyx Pharmaceutical position peaked at $38.5K in Q2 2026.
- 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.